Why claim denials are rising in 2026. The four real causes.
Initial denial rates have moved from 9 percent in 2020 to 11 to 13 percent on average across commercial books. The compounded effect on net revenue lands between 3 and 7 percent of gross. The causes are not a mystery. Four levers are moving at once, and most practices are still operating against a 2020 playbook.
The headlineDenial rates are climbing at the fastest pace in a decade.
The number that gets quoted at every industry conference is the headline rate. Initial denials at 9 percent in 2020. Initial denials at 11 to 13 percent in 2026. The headline is real, but the headline misses the operational story. A practice that sat at 9 percent in 2020 and did nothing structural between then and now is sitting at 13 to 16 percent today, and they did not earn that increase. The increase happened to them.
The compounded revenue impact is between 3 and 7 percent of gross charges, depending on payer mix and rework capacity. On a $30 million practice, that is between $900,000 and $2.1 million in cash that disappeared without anyone signing a check. The dollar value is not what gets people's attention, though. What gets attention is when the AR aging report shifts in a board meeting and nobody can say why, six weeks after the cause already happened.
The denial rate increase is real, the dollar impact is large, and the four causes are distinct enough to be fixed separately. They do not all need the same playbook.
What changedFour levers, moving in the same direction, at the same time.
If denials were going up because of one thing, the industry would have solved it by 2022. The reason the trend has accelerated rather than reversed is that four levers moved simultaneously, none of them inside the practice's control, and each of them with a different operational fix. The work of an RCM leader in 2026 is not to find the single cause. It is to assess all four against the practice's current denial mix and prioritize the fixes by dollar impact.
The four causes, in roughly the order of dollar impact across our active book: AI on the payer side, post-pandemic enrollment chaos, payer policy churn, and the healthcare worker shortage. Each one carries its own data, its own examples, and its own mitigation playbook. The mistake we see most often is treating the four causes as a single problem and throwing capacity at it. Capacity helps for two of the four. The other two need structural change.
The trend, 2020 to 2026.
Initial denial rate by year, blended across commercial, Medicare Advantage, and Medicaid managed care. The pandemic spike was real but transient. The rise since 2022 is structural.
Four levers. Four playbooks.
In order of dollar impact across our active book. Each cause has its own data signal, its own example, and its own mitigation. Throwing rework capacity at all four is the most common mistake in RCM operations.
AI on the payer side.
Every major national payer has deployed natural-language and rules-based AI on the adjudication side. The AI compares the submitted claim against medical-necessity language, prior-auth records, and historical practice patterns in milliseconds. Inconsistencies that used to slip through to payment-then-clawback now denial-out at first pass.
The single sharpest example: a behavioral health practice that had been billing 90837 for 53-minute sessions against documentation that read "approximately 50 minutes" started denying at 22 percent overnight in Q4 2024 when one MA carrier turned on a documentation-NLP edit. The fix was clinical documentation timing language, not a billing change.
Post-pandemic enrollment chaos.
The Medicaid continuous enrollment unwinding moved millions of patients across plans, into commercial, into the marketplace, and into uninsured status. The eligibility data the practice management system thinks it has is wrong on a measurable percentage of patients today. Coverage termination, plan switch, and payer-of-record mismatches drive a category of denials that did not exist at this volume in 2020.
An FQHC client of ours found that 14 percent of patients seen in any given month carried stale coverage in the PM system. The denial rate on those patients was 4.6 times the practice-wide average. The cost of real-time 270/271 verification before each encounter was 18 cents per check. The denial reduction in 60 days was 3.1 percentage points.
Payer policy churn.
The largest national payers publish 80 to 140 medical-policy updates per year. Coverage rules, prior-auth requirements, edit logic, and modifier rules update on a rolling cadence with little advance notice. Practices that refresh their internal payer rule table annually miss roughly 90 percent of those updates. The rule table becomes a year-stale fiction by Q2.
One commercial payer changed its prior-auth requirement for a common imaging code without changing the CPT description. A 200-provider multispecialty group continued submitting under the old rule for nine weeks before someone reconciled the denial pattern back to the policy update. The cost of those nine weeks was $340,000 in delayed cash and $58,000 in rework.
The healthcare worker shortage.
Coder, biller, and front-desk staffing shortages drive errors at the points in the cycle where the work is least forgiving. Missing demographic fields cause eligibility denials. Coder backlog drives late-filing denials. Untrained front-desk staff miss prior-auth flags. The labor shortage is the indirect cause of perhaps a third of denials we audit, hidden inside the other three causes.
A regional hospital group cut its denial rate 4 percentage points in a single quarter by doing two things: re-training its registration team on a 12-field demographic checklist and outsourcing posting to a credentialed offshore specialist team. The labor cost dropped 28 percent. The denial rate dropped 4 percentage points. The two outcomes are correlated, not coincidental.
The mathWhat this actually costs a practice.
The headline industry number is that denials cost healthcare $262 billion annually. The number is real, but it is too large to be operationally useful. The number a CFO can act on is the practice-level translation: every percentage point of initial denial rate above a healthy baseline costs roughly 0.4 to 0.6 percent of net revenue, after factoring in rework cost, reduced overturn yield, and accelerated AR aging.
On a $30 million practice, the difference between an 8 percent and a 13 percent initial denial rate is roughly $720,000 in annualized net revenue, plus another $180,000 in incremental rework labor. Practices that have been quietly carrying the increase as a "tough year" line item are usually misreading their own numbers. The increase is not a tough year. It is a structural operating gap that compounds quarter over quarter unless it is named and addressed.
Every percentage point of denial-rate above an 8 percent commercial baseline costs roughly 0.4 to 0.6 percent of net revenue. The cost compounds because rework drags AR aging.
The prevention mathPreventing a denial costs one tenth of overturning one.
The single most important number in denial economics is the ratio of prevention cost to overturn cost. Across the data we have run on our active book, preventing a denial through eligibility verification, documentation specificity, or payer rule application costs roughly one tenth of overturning one through the appeal cycle. The reason most denial-prevention investments fail is that practices fund the appeal team and starve the prevention team, then wonder why the denial rate keeps climbing.
A reasonable split for denial-reduction investment is 70 percent in prevention and 30 percent in appeal capacity. Prevention covers eligibility verification, documentation training, payer rule library maintenance, and pre-bill scrubbing. Appeal capacity covers a credentialed specialist team that runs the overturn workflow with AI-flagged dollar-value triage. Practices that invert that ratio are spending money chasing dollars they could have kept.
The board narrativeThe story to tell the board this quarter.
The CFO who walks into a board meeting and says "denials are up because the industry is hard" loses the room. The CFO who walks in and says "denials are up 3 percentage points, two thirds of the increase is eligibility-rooted from MCO churn, the fix is 18 cents per encounter and we will see the impact in 60 days" keeps the room. The framing is the same data; the difference is whether the story has a named cause and a named fix.
Treat the denial rate as a managed metric, not an environmental condition. Report it monthly with a year-over-year trend, a payer-class breakdown, a root-cause attribution, and a named fix per root cause. The reporting cadence is what turns the denial rate from a complaint into a project plan.
What CFOs should do this quarter.
Five actions, in order of dollar impact, that any practice can run inside a 90-day window without restructuring the team. The capital cost of all five is roughly one analyst-week and a couple of vendor contracts.
Turn on real-time eligibility verification before every encounter.
270/271 transaction at the moment of check-in, with discrepancies surfaced to the front desk before the patient is roomed. Roughly 18 cents per verification. Catches the post-PHE enrollment churn at the cycle's cheapest moment.
Refresh the payer rule library to a quarterly cadence.
Subscribe to medical policy update feeds for the top five commercial payers and the top three MA carriers. Distribute an internal one-page brief every quarter to coding and front-desk teams. Stop missing 90 percent of policy updates because the annual refresh is the only refresh.
Run a pre-bill scrubber that mirrors the payer AI logic.
Documentation NLP. Medical-necessity language check. Modifier validity. Time-of-service language for time-based codes. Catch the denial before it ships rather than appealing it after the fact. Front-loads the work to the cheapest point in the cycle.
Shift the denial spend ratio to 70 percent prevention, 30 percent appeal.
Audit the current spend mix. If prevention is under 50 percent of denial-reduction budget, the ratio is inverted and the curve will keep moving the wrong direction. Reallocate by Q3.
Report denial rate monthly with named cause and named fix.
One dashboard slide. Year-over-year trend. Payer-class breakdown. Root-cause attribution against the four causes. Named fix per cause. Send to the board, the operations team, and the senior clinical leadership. The cadence is what creates the accountability.
Rising claim denials, frequently asked questions.
Quick answers to the questions CFOs and revenue cycle leaders most often ask when the denial rate moves the wrong direction.
How much have claim denial rates actually risen?
What is driving the AI-powered payer denials?
Why is post-pandemic enrollment chaos still affecting denials?
What is payer policy churn and how often does it happen?
How is the healthcare worker shortage causing denials?
What is the single highest-leverage fix this quarter?
Should we appeal more denials or prevent more denials?
What does a healthy denial rate look like in 2026?
Want a denial audit on your real data?
A free 30-day denial audit under a same-day BAA. The output is a written report covering denial rate by payer class, root-cause attribution against the four causes, dollar value of preventable denials, and a 90-day fix plan. A senior partner on the call.